PSC gets more time at Chiliogali

|

Published 18-FEB-2016 10:52 A.M.

|

1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Prospect Resources (ASX:PSC) will have another month to decide whether or not to take up a key graphite license in Tanzania after it extended the option window on the project.

Back in November PSC told investors that it had acquired an option on the Chiliogali project in Tanzania, diversifying away from its more traditional base of gold projects in Southern Africa.

At the time, the option had a three-month window in which PSC could elect to take up the project, but PSC and current owner ASAB Resources have decided to extend the option agreement by another month.

The initial exploration on the project has been positive, with early work finding graphite of up to 1000 microns, comfortably considered to be in the jumbo to super-jumbo range.

The testing also found that there would be little issue in liberating the graphite from the ore, with it finding that the graphite was not intergrown in the quartz – which can be an issue for some graphite projects.

Previous chip sampling from trenches at the project brought up grades of:

Peak grade 33.2% TGC

150 samples > 5% TGC, with

114 samples > 10% TGC

41 samples > 20% TGC

At this stage the project is still in the very early exploration phase, but PSC is ultimately hoping that the project’s location relatively close to the Mtwara deepwater port will help the economics of the project.

The project is about 180km west of the port, which has access in from the well-maintained Masao-Lindi-Mtwara road.

The company has claimed that in the limited metallurgical test work done to date at the project, that concentrates of more than 98% are possible when undergoing floatation work.

tags

GRAPHITE


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X